Skip to main content

Table 1 Clinical character of ESCC patients

From: Overexpression of DNA damage-induced 45 α gene contributes to esophageal squamous cell cancer by promoter hypomethylation

Patient/age/sex

T/N/M/G

Condition of one year after operation

1/64/M

T3/N1b/M0/G1-G2

alive

2/68/M

T3/N0/M0/G1

alive

3/58/M

T3/N0/M0/G1

alive

4/61/M

T0/N0/M0/G1

alive

5/63/M

T1b/N0/M0/G2

alive

6/76/F

T2/N0/M0/G3

alive

7/62/M

T3/N1a/M0/G1

alive

8/55/M

T3/N1a/M0/G2

alive

9/63/M

T2/N1a/M0/G2

alive

10/47/M

T2/N1a/M0/G1

alive

11/42/M

T2/N0/M0/G2

alive

12/55/M

T3/N0/M0/G1

alive

13/56/M

T1b/N0/M0/G1-G2

alive

14/56/M

T3/N1a/M0/G1

dead

15/73/M

T4/N0/M1/G2-G3

alive

16/61/M

T3/N0/M0/G2

alive

17/67/M

T2/N0/M0/G2

alive

18/59/M

T2/N1a/M0/G2

alive

19/55/M

T3/N1b/M0/G2

alive

20/58/M

T3/N1a/M0/G2

alive

21/57/M

T2/N1a/M0/G2

alive

22/65/M

T2/N1a/M0/G2-G3

metastasis in lymph node of nest

23/54/M

T3/N1a/M0/G2

alive

24/56/M

T3/N0/M0/G2

alive

25/74/M

T2/N1a/M0/G2

metastasis in lymph node of nest

26/51/M

T2/N1b/M0/G1

alive

27/52/M

T3/N1a/M0/G1

alive

28/60/M

T2/N1a/M0/G2

alive

29/47/M

T2/N0/M0/G2

alive

30/55/M

T3/N1b/M0/G2

alive

31/68/M

T3/N0/M0/G2

alive

32/71/M

T3/N1a/M0/G2

alive

33/55/M

T2/N0/M0/G1

alive

34/69/M

T2/N0/M0/G2

alive

35/55/M

T2/N1b/M0/G2

alive

36/59/M

T2/N1b/M0/G1-G2

metastasis in liver

37/60/M

T2/N0/M0/G2

alive

38/54/M

T2/N1a/M0/G2

alive

39/62/M

T3/N1b/M0/G2

alive

40/59/M

T1b/N0/M0/G1-G2

alive